Preparing a patient-specific cellular immunotherapy supply chain for commercialisationPublished: October 3, 2019
Dirk De Naeyer
Supply Chain Focus: Biologistics Strategy for Scale-Up
Dirk De Naeyer is the Chief Operating Officer of Kiadis and an experienced executive in Life Sciences and Biotech, with a sustained track record of leading organizations through complex change and enabling them to deliver growth and operational performance. He possesses broad experience in Operations and R&D (supply chain, manufacturing, R&D, procurement) as a leader of global and local teams, as well as post-merger integrations.DOI: 10.18609/cgti.2019.119
Citation: Cell & Gene Therapy Insights 2019; 5(9), 1117–1123.